Gregory Owens Jr., Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2525 Ne 139th St, Suite 210, Vancouver, WA 98686 Phone: 360-882-2778 Fax: 360-604-1739 |
Dr. Carrie Nicole Caruthers, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2525 Ne 139th St, Suite 210, Vancouver, WA 98686 Phone: 360-882-2778 |
Laura J Davis, MD Allergy & Immunology - Allergy Medicare: Accepting Medicare Assignments Practice Location: 14508 Ne 20th Ave, #200, Vancouver, WA 98686 Phone: 360-695-8553 Fax: 360-737-3713 |
Carolyn R Comer, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 16821 Se Mcgillivray Blvd, Suite 110, Vancouver, WA 98683 Phone: 360-567-1773 Fax: 360-567-1967 |
Dr. Sanjeev Jain, M.D.; PHD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1406 Se 164th Ave, Suite 250, Vancouver, WA 98683 Phone: 360-834-6700 Fax: 360-834-6765 |
George S Allen, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 8506 E Mill Plain Blvd, Suite A, Vancouver, WA 98664 Phone: 360-896-2222 Fax: 360-896-8881 |
News Archive
How does a tumor cell set up a signaling pathway in order to metastasize? Scientists at Technische Universit-t M-nchen's (TUM) Klinikum rechts der Isar and Helmholtz Zentrum M-nchen have made a significant discovery in this area by studying colon cancer.
The Program Committee is pleased to announce the call for papers for the Pittcon 2018 Technical Program. Abstracts are currently being accepted for contributed oral and poster presentations in all areas of analytic chemistry and applied spectroscopy in applications such as, but not limited to, environmental science, food science, energy research, and informatics.
Scancell Holdings Plc,, the developer of therapeutic cancer vaccines, is pleased to announce it has signed a worldwide non-exclusive licensing agreement with the National Institutes of Health ('NIH'), a division of the U.S. Department of Health and Human Services, for use of the melanoma antigens TRP-2 and gp100, key components of Scancell's lead ImmunoBody® vaccine for melanoma, SCIB1.
A team of Danish investigators has shown how to identify pathogens faster, directly from clinical samples. The research, published online ahead of print in the Journal of Clinical Microbiology appears in the journal's January 2014 issue.
› Verified 7 days ago